PDT Partners »

Mineralys Therapeutics shares owned by PDT Partners

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by PDT Partners from 13F filings

Historical chart of PDT Partners investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by PDT Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by PDT Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $120k 14k 8.60
2023-09-30 $132k 14k 9.51

More positions owned by PDT Partners

Ferrari Nv Ord (RACE)
Cme (CME)
Stellantis SHS (STLA)
Atkore Intl (ATKR)
Airbnb Com Cl A (ABNB)
Medpace Hldgs (MEDP)
Robinhood Mkts Com Cl A (HOOD)
Confluent Class A Com (CFLT)
Snowflake Cl A (SNOW)
Nvent Electric SHS (NVT)
10x Genomics Cl A Com (TXG)
Samsara Com Cl A (IOT)
Gitlab Class A Com (GTLB)
Roblox Corp Cl A (RBLX)
Atlassian Corporation Cl A (TEAM)

View all positions for PDT Partners

Top funds holding Mineralys Therapeutics

Samsara BioCapital
RA Capital Management
Braidwell
Sr One Capital Management
BlackRock
Laurion Capital Management
Vanguard Group
Sphera Funds Management
Franklin Resources
Blue Owl Capital Holdings
Millennium Management
Point72 Asset Management
Charles Schwab Investment Management
Citadel Advisors
Two Sigma Investments

View all funds holding Mineralys Therapeutics